PURPOSE
The high energy (511 keV) annihilation photons used in positron emission tomography (PET) imaging generally require a substantial amount of lead to protect personnel and the general public from ionizing radiation. A cost-effective design of the PET facility that ensures radiation does not exceed formal dose limits requires accurate estimation of the necessary PET shielding. The American Association of Physicists in Medicine (AAPM) Task Group 108 recently published broad beam transmission factors based on Monte Carlo calculations of 511 keV photons. In this work, an extension to the AAPM model is presented, based on Monte Carlo simulations including the effects of self-absorption on the photon energy spectrum.
METHODS
Monte Carlo calculations were performed usingMCNPX. The photon energy spectrum after self-absorption was computed by simulating a normal F18DG activity distribution in an anthropomorphic phantom. This spectrum was used to calculate the dose rate transmission factors for various wall thicknesses of lead, concrete, and iron. The method was validated by measurement and corresponding simulation of the transmission factors of an F18DG source in air and in PMMA. Furthermore, a method to generate 3D area dose rate maps of PET facilities incorporating the calculated transmission tables is presented and applied to several shielding situations.
RESULTS
The calculated self-absorption correction factor and the broad beam transmission factors resulting from Monte Carlo simulations of a monoenergetic point source emitting 511 keV photons were in excellent agreement with the results of the AAPM publication (0.66 vs 0.64 and R2=0.999, respectively). However, when all radiation physics, i.e., also the effect of self-absorption on the photon energy spectrum, is included in the Monte Carlo calculations, a substantial reduction in required shielding material was found. For example, including all radiation physics leads to 13.3 mm of lead required to obtain a typical transmission factor of 0.1, instead of 16.0 mm of lead when the AAPM data including only the self-absorption correction factor are used. These findings were confirmed by the experimental measurements. The transmission factors produced in this work can be applied in the same manner as those estimated by AAPM to allow for a cost-effective design of PET and PET/CT facilities without violating radiation safety regulations.
CONCLUSIONS
Taking into account the effect of self-absorption on the photon energy spectrum results in more accurate and cost-effective shielding requirement estimations.
[1]
J C Courtney,et al.
Photon shielding for a positron emission tomography suite.
,
2001,
Health physics.
[2]
L. Dauer,et al.
Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
,
2008,
Health physics.
[3]
D J Simpkin,et al.
Shielding requirements for constant-potential diagnostic x-ray beams determined by a Monte Carlo calculation.
,
1989,
Health physics.
[4]
Michael J Pentecost,et al.
American College of Radiology white paper on radiation dose in medicine.
,
2007,
Journal of the American College of Radiology : JACR.
[5]
Mark T Madsen,et al.
AAPM Task Group 108: PET and PET/CT shielding requirements.
,
2005,
Medical physics.
[6]
S. Savolainen,et al.
Personal radiation doses in PET/CT facility: measurements vs. calculations.
,
2008,
Radiation protection dosimetry.
[7]
H. Kharrati,et al.
Monte Carlo simulation of x-ray buildup factors of lead and its applications in shielding of diagnostic x-ray facilities.
,
2007,
Medical physics.
[8]
Eric C. Frey,et al.
Quantitative cardiac SPECT reconstruction with reduced image degradation due to patient anatomy
,
1993
.
[9]
S C Bushong,et al.
Diagnostic X-ray shielding design based on an empirical model of photon attenuation.
,
1983,
Health physics.
[10]
Brian M Methé,et al.
Shielding Design for a PET Imaging Suite: A Case Study
,
2003,
Health physics.
[11]
Zhengrong Liang,et al.
A fast ray-tracing technique for TCT and ECT studies
,
1999,
1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).
[12]
J. Votaw,et al.
A comparison of AAPM TG-108 PET/CT shielding recommendations to measurements in an oncology center.
,
2009,
Medical physics.
[13]
J. Hatazawa,et al.
Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.
,
1991,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.